September 2, 2015 | Teva Pharmaceutical Industries will begin to market ZECUITY, a patch system that provides relief from migraine headaches. The single-use, disposable patch will now be available by prescription in the United States. In order for it to work effectively, ZECUITY must be worn for four-hours on the upper arm or leg. Teva was founded in 1901 and is headed by CEO Erex Vigodman.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments